Quarterly report [Sections 13 or 15(d)]

Stock Based Compensation (Tables)

v3.25.0.1
Stock Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity under our equity compensation plans:

 

Number of
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term

 

 

Aggregate Intrinsic Value ('000)

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Options outstanding as of December 31, 2023

 

 

2,198,552

 

 

$

17.11

 

 

 

5.0

 

 

 

 

Granted

 

 

33,901

 

 

$

10.17

 

 

 

 

 

 

 

Exercised

 

 

(37,758

)

 

$

7.13

 

 

 

 

 

 

 

Forfeited, canceled, or expired

 

 

(196,734

)

 

$

21.66

 

 

 

 

 

 

 

Options outstanding as of September 30, 2024

 

 

1,997,961

 

 

$

16.74

 

 

 

4.7

 

 

$

1,117

 

Vested and expected to vest at September 30, 2024

 

 

1,997,961

 

 

$

16.74

 

 

 

4.7

 

 

$

1,117

 

Exercisable at September 30, 2024

 

 

1,912,896

 

 

$

16.56

 

 

 

4.6

 

 

$

1,117

 
Summary of Restricted Stock Units Activity

The following table summarizes restricted stock unit ("RSU") activity under the 2021 Plan:

 

 

 

 

Number of RSUs

 

 

Weighted Average Grant Date Fair Value per Share

 

Outstanding as of December 31, 2023

 

 

 

 

1,847,583

 

 

$

10.17

 

RSUs granted

 

 

 

 

3,101,757

 

 

$

12.09

 

RSUs vested

 

 

 

 

(907,182

)

 

$

11.18

 

RSUs forfeited

 

 

 

 

(857,204

)

 

$

13.05

 

Outstanding as of September 30, 2024

 

 

 

 

3,184,954

 

 

$

10.97

 

 
Schedule of Stock Based Compensation Expense Based on Roles and Responsibilities of Employees

The following table summarizes the components of total stock-based compensation expense based on roles and responsibilities of the employees within the condensed consolidated statements of operations:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of revenue

 

$

58

 

 

$

48

 

 

$

182

 

 

$

173

 

Research and development

 

 

1,180

 

 

 

957

 

 

 

3,408

 

 

 

2,510

 

Sales and marketing

 

 

893

 

 

 

673

 

 

 

2,512

 

 

 

1,729

 

General and administrative

 

 

2,828

 

 

 

1,852

 

 

 

7,280

 

 

 

5,104

 

 

$

4,959

 

 

$

3,530

 

 

$

13,382

 

 

$

9,516